CIK 0000200406 · Large accelerated filer
JOHNSON & JOHNSON
Sign in to watch- Ticker
- JNJ
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Jan 3
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 221024240
- Phone
- 732-524-2455
- Business address
- ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, 08933
- Former names
- JOHNSON & JOHNSON ET AL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,898,386
- in 3 filings
Net −$16,898,386. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-23 | West Nadja Director | Grant or award · Deferred Share Units | +975 | 7,730.05 | ||
| 2026-04-23 | WEINBERGER MARK A Director | Grant or award · Deferred Share Units | +975 | 12,010.41 | ||
| 2026-04-23 | Pinto Daniel E Director | Grant or award · Deferred Share Units | +1,712 | 2,174.07 | ||
| 2026-04-23 | MORIKIS JOHN G Director | Grant or award · Deferred Share Units | +1,540 | 1,540 | ||
| 2026-04-23 | McClellan Mark B. Director | Grant or award · Deferred Share Units | +975 | 21,278.59 | ||
| 2026-04-23 | Joly Hubert Director | Grant or award · Deferred Share Units | +975 | 9,183.61 | ||
| 2026-04-23 | Johnson Paula A Director | Grant or award · Deferred Share Units | +975 | 5,359.4 | ||
| 2026-04-23 | HEWSON MARILLYN A Director | Grant or award · Deferred Share Units | +975 | 15,487.94 | ||
| 2026-04-23 | Doudna Jennifer A Director | Grant or award · Deferred Share Units | +975 | 10,899.17 | ||
| 2026-04-23 | Beckerle Mary C Director | Grant or award · Deferred Share Units | +975 | 16,797.74 | ||
| 2026-03-10 | HEWSON MARILLYN A Director | Grant or award · Deferred Share Units | +206.49 | $242.14 | $50K | 14,512.94 |
| 2026-03-10 | Pinto Daniel E Director | Grant or award · Deferred Share Units | +129.06 | $242.14 | $31K | 462.07 |
| 2026-03-10 | Woods Eugene A. Director | Grant or award · Deferred Share Units | +154.87 | $242.14 | $37K | 5,240.09 |
| 2026-02-27 | Decker Robert J VP Corporate Controller | Option exercise | +4,075 | $115.67 | $471K | 27,757 |
| 2026-02-27 | Decker Robert J VP Corporate Controller | Sale | −4,075 | $247.87 | $1.0M | 23,682 |
| 2026-02-27 | Decker Robert J VP Corporate Controller | Option exercise · Employee Stock Options (Right to Buy) | −4,075 | 0 | ||
| 2026-02-20 | Schmid Timothy EVP, WW Chair, MedTech | Sale | −1,322 | $245.66 | $325K | 25,447 |
| 2026-02-18 | Schmid Timothy EVP, WW Chair, MedTech | Option exercise | +13,625 | $115.67 | $1.6M | 40,394 |
| 2026-02-18 | Schmid Timothy EVP, WW Chair, MedTech | Sale | −13,625 | $244.20 | $3.3M | 26,769 |
| 2026-02-18 | Schmid Timothy EVP, WW Chair, MedTech | Option exercise | +8,998 | $129.51 | $1.2M | 35,767 |
Page 3 of 19 · 365 trades